Literature DB >> 7716703

The role of cytokines in the immunopathogenesis of lupus.

B S Handwerger1, V Rus, L da Silva, C S Via.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7716703     DOI： 10.1007/bf00197515

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  207 in total

1.  Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G Semenzato; L M Bambara; D Biasi; A Frigo; F Vinante; B Zuppini; L Trentin; C Feruglio; M Chilosi; G Pizzolo
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

Review 2.  Molecular characterization of interleukin 2.

Authors:  S Gillis; D Y Mochizuki; P J Conlon; S H Hefeneider; C A Ramthun; A E Gillis; M B Frank; C S Henney; J D Watson
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 3.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

4.  Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Saito; F Shirakawa; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

5.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

6.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.

Authors:  D H Campen; D A Horwitz; F P Quismorio; G R Ehresmann; W J Martin
Journal:  Arthritis Rheum       Date:  1988-11

7.  Spontaneous production of B cell growth factors by SLE lymphocytes.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

8.  T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.

Authors:  A M Draeger; A J Swaak; H G van den Brink; L A Aarden
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

9.  Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.

Authors:  A D Steinberg; J B Roths; E D Murphy; R T Steinberg; E S Raveche
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells.

Authors:  I Kobayashi; T Matsuda; T Saito; K Yasukawa; H Kikutani; T Hirano; T Taga; T Kishimoto
Journal:  Int Immunol       Date:  1992-12       Impact factor: 4.823
View more
  12 in total

1.  The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus.

Authors:  E Eilat; M Dayan; H Zinger; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis.

Authors:  Y Nishitani; A Kubo; M Iwano; N Minamino; K Hamano; T Fujimoto; T Nishino; H Shiiki; K Yonemasu; K Dohi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 3.  Lessons from animal models of vasculitis.

Authors:  I G Luzina; B S Handwerger
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

4.  A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.

Authors:  Dror Luger; Molly Dayan; Heidy Zinger; Jian-Ping Liu; Edna Mozes
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

5.  Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Authors:  Charles S Via; Gene M Shearer
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

6.  T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.

Authors:  M G Papamattheou; J G Routsias; E E Karagouni; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas; E N Dotsika
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.

Authors:  D M Chang; S J Chu; H C Chen; S Y Kuo; J H Lai
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

Review 8.  Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction.

Authors:  P M Moore; R P Lisak
Journal:  Springer Semin Immunopathol       Date:  1995

9.  Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.

Authors:  Shui-Lian Yu; Chun-Kwok Wong; Purple Tsz-Yan Wong; Da-Peng Chen; Cheuk-Chun Szeto; Edmund K Li; Lai-Shan Tam
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

10.  Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.

Authors:  E Waszczykowska; E Robak; A Wozniacka; J Narbutt; J D Torzecka; A Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.